Trans-Hit Biomarkers Invited to the Autm 2011 Annual Meeting (Feb 27 - Mar 2, 2011, Las Vegas) to Participate in an Expert Panel on Biomarkers and Companion Diagnostics

On March 2, 2011, Trans-Hit Biomarkers will participate in an expert panel discussion “Mastering the World of Biomarkers and Companion Diagnostics” at the 2011 Annual Meeting of the Association of University Technology Managers (AUTM) in Las Vegas.

Panelists include:

Michael F. Perham ,University of Virginia Patent Foundation Monte Wetzel , Roche Molecular Systems Inc. Jason Cristofaro , National Institutes of Health Pascal Puchois, Trans-Hit Biomarkers Inc.

 The main objective of this panel is to address biomarker-specific issues for Technology Transfer Offices, to increase the value of biomarker inventions and to effectively out-license newly discovered biomarkers and companion diagnostics to industry.

“Understanding key issues in biomarker development and providing new solutions to address the existing gaps between discovery and commercialization of biomarkers by academic scientists should improve technology transfer professionals’ likelihood of success in transferring their biomarkers to the marketplace" said Pascal Puchois, CEO of Trans-Hit Biomarkers.

Please click here for more information about this AUTM event.

About Trans-Hit Biomarkers: Trans-Hit Biomarkers is a privately held company whose mission is to advance innovative biomarkers into more valuable and competitive products. Trans-Hit Biomarkers is a collaborative research organization forging strong partnerships between technology transfer offices, human biobanks, CROs, and diagnostic companies.

Services to TTOs include: the evaluation of biomarker programs with respect to future market environment and regulatory requirements, the free listing of biomarker out-licensing opportunities on our B4B-Hub, the design of an R&D and intellectual property strategy, and R&D tools to quickly generate a reliable and valuable clinical proof-of-concept for successful out-licensing. To learn more about Trans-Hit Biomarkers and its B4B-Hub, visit For any inquiries, contact: [email protected]

About AUTM: AUTM ( was founded in 1974 as the Society of University Patent Administrators, with the objective of addressing a concern that inventions funded by the US government were not being commercialized effectively. Through the years AUTM has grown beyond this single objective and now provides professional development and networking opportunities for technology transfer professionals at all career levels, from established and newly forming organizations worldwide.